VF
MBIO icon

Virtu Financial’s Mustang Bio MBIO Stock Holding History

Virtu Financial’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-604
Closed -$31K – 1645
2024
Q1 		$31K Buy
+604
New +$38.4K ﹤0.01% 1100
2023
Q1 		– Sell
-54
Closed -$16K – 1836
2022
Q4 		$16K Buy
+54
New +$18.4K ﹤0.01% 1306
2022
Q3 		– Sell
-177
Closed -$78K – 2013
2022
Q2 		$78K Buy
177
+156
+743% +$86.4K 0.01% 1000
2022
Q1 		$16K Sell
21
-6
-22% -$4.93K ﹤0.01% 1323
2021
Q4 		$34K Buy
+27
New +$43.6K ﹤0.01% 1422
2021
Q3 		– Sell
-156
Closed -$389K – 1770
2021
Q2 		$389K Buy
156
+65
+71% +$159K 0.04% 590
2021
Q1 		$227K Sell
91
-159
-64% -$473K 0.02% 1005
2020
Q4 		$710K Buy
250
+206
+468% +$492K 0.08% 329
2020
Q3 		$105K Buy
+44
New +$108K 0.02% 712

Other funds holding MBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.15B AUM 25.5% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Virtu Financial's MBIO Position: Q2 2024 in Review

Virtu Financial sold out of Mustang Bio (MBIO) in Q2 2024, closing a stake of 604 shares — an estimated $31K sold.

Virtu Financial first reported a position in MBIO in Q3 2020 and held it in 9 quarters. The position peaked at $710K in Q4 2020. 28 funds tracked by Wall St. Rank hold MBIO as of Q2 2024.

  • Virtu Financial reported no remaining Mustang Bio position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 604 Mustang Bio shares in Q2 2024, an estimated $31K.
  • Virtu Financial first reported a position in Mustang Bio in Q3 2020 and held it in 9 quarters.
  • Virtu Financial's Mustang Bio position peaked at $710K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.